Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2012

01-06-2012 | Original Article

Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation

Authors: Ki Tae Yoon, Sun Min Lim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Mong Cho, Jun Woo Lee, Seung Up Kim

Published in: Digestive Diseases and Sciences | Issue 6/2012

Login to get access

Abstract

Background

Acoustic radiation force impulse (ARFI) elastography can be used to assess the degree of liver fibrosis.

Aim

We evaluated the performance of ARFI elastography in assessment of liver fibrosis and compared it with the performance of aspartate aminotransferase-to-platelet ratio index (APRI) and transient elastography with Fibroscan (FS).

Methods

We prospectively analyzed 250 consecutive patients who underwent liver biopsy and ARFI from June 2010 to May 2011. Reliable FS values were obtained for 97 (38.8%) patients.

Results

The mean age of patients (147 male and 103 female) was 46.6 years. Liver stiffness values obtained by use of ARFI elastography significantly correlated with histological fibrosis stage (R = 0.575, P < 0.001). Area under the receiver operating characteristics curves (AUROCs) of ARFI elastography for predicting significant fibrosis (≥F2) and cirrhosis (F4) was 0.74 (95% confidence interval [CI], 0.64–0.86, P = 0.001) and 0.79 (95% CI, 0.67–0.91, P = 0.001), respectively, and those for APRI were 0.69 (95% CI, 0.58–0.79, P = 0.001) and 0.76 (95% CI, 0.64–0.85, P < 0.001), respectively. The optimum cutoff values for ARFI elastography were 1.13 m/s for ≥F2 and 1.98 m/s for F4; these decreased to 1.09 m/s for ≥F2 and 1.81 m/s for F4 when 131 patients with normal alanine aminotransferase (ALT) were selected. In the sub-group of 97 patients with reliable FS values, the performance in predicting ≥F2 or F4 was equivalent between ARFI elastography and FS.

Conclusions

ARFI elastography is a reliable surrogate marker of liver fibrosis, if its relationship with biochemical markers, for example ALT level, is taken into account.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl JMed. 2001;344:495–500.CrossRef Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl JMed. 2001;344:495–500.CrossRef
2.
go back to reference Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the French association for the study of the liver (AFEF). Hepatology. 2000;32:477–481.PubMedCrossRef Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the French association for the study of the liver (AFEF). Hepatology. 2000;32:477–481.PubMedCrossRef
3.
go back to reference Castera L, Negre I, Samii K, et al. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30:1529–1530.PubMedCrossRef Castera L, Negre I, Samii K, et al. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30:1529–1530.PubMedCrossRef
4.
go back to reference Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut. 2006;55:403–408.PubMedCrossRef Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut. 2006;55:403–408.PubMedCrossRef
5.
go back to reference Sporiea I, Sirli R, Popescu A, et al. Acoustic radiation force impulse (ARFI)—a new modality for the evaluation of liver fibrosis. Med Ultrason. 2010;12:26–31. Sporiea I, Sirli R, Popescu A, et al. Acoustic radiation force impulse (ARFI)—a new modality for the evaluation of liver fibrosis. Med Ultrason. 2010;12:26–31.
6.
go back to reference Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41:1376–1382.PubMedCrossRef Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41:1376–1382.PubMedCrossRef
7.
go back to reference Kim SU, Park JU, Kim DY, et al. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression. HepatolInt. 2010;4:673–680.CrossRef Kim SU, Park JU, Kim DY, et al. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression. HepatolInt. 2010;4:673–680.CrossRef
8.
go back to reference Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (Fibroscan). Hepatology. 2011;53:885–894.PubMedCrossRef Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (Fibroscan). Hepatology. 2011;53:885–894.PubMedCrossRef
9.
go back to reference Talwalker JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. ClinGastroenterolhepatol. 2007;5:1214–1220. Talwalker JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. ClinGastroenterolhepatol. 2007;5:1214–1220.
10.
go back to reference de Ledinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography using FS using a new probe for obese patients. Liver Int. 2010;30:1043–1048.PubMedCrossRef de Ledinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography using FS using a new probe for obese patients. Liver Int. 2010;30:1043–1048.PubMedCrossRef
11.
go back to reference Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–384.PubMedCrossRef Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–384.PubMedCrossRef
12.
go back to reference Rifai K, Cornberg J, Mederacke I, et al. Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). Dig Liver Dis. 2011;43:491–497.PubMedCrossRef Rifai K, Cornberg J, Mederacke I, et al. Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). Dig Liver Dis. 2011;43:491–497.PubMedCrossRef
13.
go back to reference Sporea I, Sirli RL, Deleanu A, et al. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med. 2011;32:S46–S52.PubMedCrossRef Sporea I, Sirli RL, Deleanu A, et al. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med. 2011;32:S46–S52.PubMedCrossRef
14.
go back to reference Takahashi H, Ono N, Eguchi Y, et al. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int. 2010;30:538–545.PubMedCrossRef Takahashi H, Ono N, Eguchi Y, et al. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int. 2010;30:538–545.PubMedCrossRef
15.
go back to reference Kim SU, Han KH, Park JY, et al. Liver stiffness measurement using FS is influenced by serum total bilirubin in acute hepatitis. Liver Int. 2009;29:810–815.PubMedCrossRef Kim SU, Han KH, Park JY, et al. Liver stiffness measurement using FS is influenced by serum total bilirubin in acute hepatitis. Liver Int. 2009;29:810–815.PubMedCrossRef
16.
go back to reference Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology. 2009;252:595–604.PubMedCrossRef Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology. 2009;252:595–604.PubMedCrossRef
17.
go back to reference Toshima T, Shirabe K, Takeishi K, et al. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol. 2011;46:705–711.PubMedCrossRef Toshima T, Shirabe K, Takeishi K, et al. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol. 2011;46:705–711.PubMedCrossRef
18.
go back to reference Goertz RS, Zopf Y, Jugl V, et al. Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fibrosis in viral hepatitis. Ultraschall Med. 2010;31:151–155.PubMedCrossRef Goertz RS, Zopf Y, Jugl V, et al. Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fibrosis in viral hepatitis. Ultraschall Med. 2010;31:151–155.PubMedCrossRef
19.
go back to reference Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology. 2010;256:640–647.PubMedCrossRef Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology. 2010;256:640–647.PubMedCrossRef
20.
go back to reference Kim SU, Choi GH, Han WK, et al. What are ‘true normal’ liver stiffness values using Fibroscan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int. 2009;30:268–274.PubMedCrossRef Kim SU, Choi GH, Han WK, et al. What are ‘true normal’ liver stiffness values using Fibroscan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int. 2009;30:268–274.PubMedCrossRef
21.
go back to reference Kim SU, Kim DY, Park JY, et al. How can we enhance the performance of liver stiffness measurement using Fibroscan in diagnosing liver cirrhosis in patients with chronic hepatitis B. J Clin Gastroenterol. 2010;44:66–71.PubMedCrossRef Kim SU, Kim DY, Park JY, et al. How can we enhance the performance of liver stiffness measurement using Fibroscan in diagnosing liver cirrhosis in patients with chronic hepatitis B. J Clin Gastroenterol. 2010;44:66–71.PubMedCrossRef
22.
go back to reference Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol. 1995;19:1409–1417.PubMedCrossRef Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol. 1995;19:1409–1417.PubMedCrossRef
23.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845.PubMedCrossRef DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845.PubMedCrossRef
25.
go back to reference Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54.PubMedCrossRef Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54.PubMedCrossRef
26.
go back to reference Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using Fibroscan in a prospective study of 2,114 examinations. Eur J Gastroenterol Hepatol. 2006;18:411–412.PubMedCrossRef Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using Fibroscan in a prospective study of 2,114 examinations. Eur J Gastroenterol Hepatol. 2006;18:411–412.PubMedCrossRef
27.
go back to reference Kim SU, Seo YS, Cheong JY, et al. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2010;32:498–505.PubMedCrossRef Kim SU, Seo YS, Cheong JY, et al. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2010;32:498–505.PubMedCrossRef
28.
go back to reference Ebimura H, Saito H, Komuta M, et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with FS. J Gastroenterol. 2011. (Epub ahead of print). doi:10.1007/s00535-011-0437-3. Ebimura H, Saito H, Komuta M, et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with FS. J Gastroenterol. 2011. (Epub ahead of print). doi:10.​1007/​s00535-011-0437-3.
29.
go back to reference Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FS) irrespective of fibrosis. Hepatology. 2008;48:1718–1723.PubMedCrossRef Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FS) irrespective of fibrosis. Hepatology. 2008;48:1718–1723.PubMedCrossRef
30.
go back to reference Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010;52:206–210.PubMedCrossRef Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010;52:206–210.PubMedCrossRef
31.
go back to reference Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360–369.PubMedCrossRef Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360–369.PubMedCrossRef
32.
go back to reference Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unrealiable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592–595.PubMedCrossRef Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unrealiable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592–595.PubMedCrossRef
33.
go back to reference Bechmann LP, Marquitan G, Jochum C, Saner F, Gerken G, Canbay A. Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure. Liver Int. 2008;28:713–716.PubMed Bechmann LP, Marquitan G, Jochum C, Saner F, Gerken G, Canbay A. Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute-on-chronic liver failure. Liver Int. 2008;28:713–716.PubMed
34.
go back to reference Singhal S, Jain S, Kohaar I, Singla M, Gondal R, Kar P. Apoptotic mechanism in fulminant hepatic failure: potential therapeutic target. Appl Immunohistochem Mol Morphol. 2009;17:282–285.PubMedCrossRef Singhal S, Jain S, Kohaar I, Singla M, Gondal R, Kar P. Apoptotic mechanism in fulminant hepatic failure: potential therapeutic target. Appl Immunohistochem Mol Morphol. 2009;17:282–285.PubMedCrossRef
35.
go back to reference Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (FS) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 2009;16:36–44.PubMedCrossRef Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (FS) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 2009;16:36–44.PubMedCrossRef
36.
go back to reference Rizzo L, Calvaruso V, Cacopardo B, et al. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol. 2011. (Epub ahead of print). doi:10.1038/ajg.2011.341. Rizzo L, Calvaruso V, Cacopardo B, et al. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol. 2011. (Epub ahead of print). doi:10.​1038/​ajg.​2011.​341.
37.
go back to reference Lupsor M, Badea R, Stefanescu H, et al. Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results. J Gastrointest Liver Dis. 2009;18:303–310. Lupsor M, Badea R, Stefanescu H, et al. Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results. J Gastrointest Liver Dis. 2009;18:303–310.
38.
go back to reference Ogawa E, Furusyo N, Toyoda K, et al. Transient elastography for patients with chronic hepatitis B and C virus infection: noninvasive, quantitative assessment of liver fibrosis. Hepatol Res. 2007;37:1002–1010.PubMedCrossRef Ogawa E, Furusyo N, Toyoda K, et al. Transient elastography for patients with chronic hepatitis B and C virus infection: noninvasive, quantitative assessment of liver fibrosis. Hepatol Res. 2007;37:1002–1010.PubMedCrossRef
39.
go back to reference Sporea I, Sirli R, Deleanu A, et al. Liver stiffness measurements in patients with HBV vs. HCV chronic hepatitis: a comparative study. World J Gastroenterol. 2010;16:4832–4837.PubMedCrossRef Sporea I, Sirli R, Deleanu A, et al. Liver stiffness measurements in patients with HBV vs. HCV chronic hepatitis: a comparative study. World J Gastroenterol. 2010;16:4832–4837.PubMedCrossRef
40.
go back to reference Kim SU, Han KH, Ahn SH. Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol. 2007;16:5173–5180.CrossRef Kim SU, Han KH, Ahn SH. Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol. 2007;16:5173–5180.CrossRef
41.
go back to reference Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51:454–462.PubMedCrossRef Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51:454–462.PubMedCrossRef
42.
go back to reference Gómez-Dominquez E, Mendoza J, García-Buey L, et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther. 2008;27:441–447.CrossRef Gómez-Dominquez E, Mendoza J, García-Buey L, et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther. 2008;27:441–447.CrossRef
43.
go back to reference Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118–1124.PubMedCrossRef Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118–1124.PubMedCrossRef
Metadata
Title
Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation
Authors
Ki Tae Yoon
Sun Min Lim
Jun Yong Park
Do Young Kim
Sang Hoon Ahn
Kwang-Hyub Han
Chae Yoon Chon
Mong Cho
Jun Woo Lee
Seung Up Kim
Publication date
01-06-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2044-4

Other articles of this Issue 6/2012

Digestive Diseases and Sciences 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine